Security key
405024100
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)
CUSIP: 405024100
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common stock, $.01 par value per share
- Total 13F shares
- 54,635,388
- Total 13F value
- $2,216,655,714
- Share change
- +8,304,395
- SEC-reported price per share
- $40.57
- Number of holders
- 176
- Value change
- +$337,134,900
- Number of buys
- 91
- Number of sells
- 77
- Shares outstanding
- 46,498,422
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
176
Top holders
10
HAE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 405024100
Recent filing periods:
Ownership snapshot
Top reported holders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
12%
VANGUARD GROUP INC
9.4%
BlackRock Fund Advisors
8.9%
WELLINGTON MANAGEMENT GROUP LLP
7.4%
WELLS FARGO & COMPANY/MN
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
12%
|
$217,158,000
5,401,931 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
9.4%
|
$175,361,000
4,362,238 shares
|
— | 31 Dec 2016 |
| BlackRock Fund Advisors |
13F
Company
|
8.9%
|
$166,324,000
4,137,423 shares
|
— | 31 Dec 2016 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7.4%
|
$137,415,000
3,418,261 shares
|
— | 31 Dec 2016 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
5%
|
$93,746,000
2,331,992 shares
|
— | 31 Dec 2016 |
| VICTORY CAPITAL MANAGEMENT INC |
13F
Company
|
4.6%
|
$86,738,000
2,157,654 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
176
Shares
54,635,388
Rows available
176
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
192
Q1 2017 holders
176
Holder diff
-16
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend